Analyst Ratings published Thursday September 4th 2025

9/4/25	Upgrades	Sell Neutral	X
AAPL Apple MoffettNathanson
$225
9/4/25	Reiterated	Market Perform	X
AEO American Eagle Telsey Advisory Group
$12 $18
9/4/25	Resumed	Buy	X
AKRO Akero Therapeutics H.C. Wainwright
$72
9/4/25	Downgrades	Buy Neutral	X
AMD Advanced Micro Devices Seaport Research Partners
9/4/25	Resumed	Buy	X
ARCT Arcturus Therapeutics H.C. Wainwright
$60
9/4/25	Initiated	Overweight	X
ATR AptarGroup KeyBanc Capital Markets
$220
9/4/25	Downgrades	Buy Neutral	X
BAM Brookfield Asset Mgmt BofA Securities
$68
9/4/25	Initiated	Buy	X
BDTX Black Diamond Therapeutics Guggenheim
$8
9/4/25	Initiated	Buy	X
CCCC C4 Therapeutics Guggenheim
$8
9/4/25	Upgrades	Hold Buy	X
CHRS Coherus BioSciences Maxim Group
9/4/25	Upgrades	Hold Buy	X
CPRT Copart HSBC Securities
$62
9/4/25	Reiterated	Buy	X
CRDO Credo Technology Group Needham
$85 $150
9/4/25	Reiterated	Buy	X
CRDO Credo Technology Group TD Cowen
$140 $160
9/4/25	Reiterated	Outperform	X
CRM Salesforce BMO Capital Markets
$335 $280
9/4/25	Downgrades	Buy Neutral	X
DUOL Duolingo DA Davidson
$300
9/4/25	Upgrades	In-line Outperform	X
EAT Brinker Evercore ISI
$210
9/4/25	Resumed	Overweight	X
ELF e.l.f. Beauty Piper Sandler
$150
9/4/25	Resumed	Buy	X
ETNB 89bio H.C. Wainwright
$32
9/4/25	Initiated	Buy	X
ETR Entergy Jefferies
$109
9/4/25	Reiterated	Buy	X
FIG Figma BofA Securities
$85 $69
9/4/25	Reiterated	Equal-Weight	X
FIG Figma Morgan Stanley
$80 $70
9/4/25	Reiterated	Equal Weight	X
FIG Figma Wells Fargo
$82 $70
9/4/25	Initiated	Overweight	X
IDYA IDEAYA Biosciences Barclays
$40
9/4/25	Initiated	Mkt Outperform	X
IDYA IDEAYA Biosciences Citizens JMP
$41
9/4/25	Initiated	Buy	X
JANX Janux Therapeutics Guggenheim
$72
9/4/25	Downgrades	Overweight Eq Weight	X
KRC Kilroy Realty Barclays
$43
9/4/25	Initiated	Neutral	X
KURA Kura Oncology Guggenheim
9/4/25	Resumed	Buy	X
LAD Lithia Motors Jefferies
$400
9/4/25	Upgrades	Sec Perform Outperform	X
LDOS Leidos RBC Capital Mkts
$210
9/4/25	Initiated	Sector Weight	X
LFCR Lifecore Biomedical KeyBanc Capital Markets
9/4/25	Reiterated	Market Perform	X
M Macy’s Telsey Advisory Group
$14 $17
9/4/25	Resumed	Buy	X
MDGL Madrigal Pharmaceuticals H.C. Wainwright
$500
9/4/25	Initiated	Outperform	X
MIDD Middleby Wolfe Research
$163
9/4/25	Initiated	Outperform	X
MTZ MasTec Mizuho
$215
9/4/25	Downgrades	Neutral Underperform	X
NAVI Navient BofA Securities
$12
9/4/25	Downgrades	Buy Neutral	X
NEON Neonode Ladenburg Thalmann
$6
9/4/25	Resumed	Buy	X
NUVL Nuvalent Guggenheim
$122
9/4/25	Resumed	Buy	X
ORIC ORIC Pharmaceuticals Guggenheim
$18
9/4/25	Downgrades	Buy Hold	X
PH Parker-Hannifin Deutsche Bank
$809
9/4/25	Initiated	Neutral	X
PRIM Primoris Services Mizuho
$112
9/4/25	Initiated	Neutral	X
PWR Quanta Services Mizuho
$360
9/4/25	Resumed	Buy	X
RLAY Relay Therapeutics Guggenheim
$15
9/4/25	Initiated	Buy	X
SMMT Summit Therapeutics Guggenheim
$40
9/4/25	Resumed	Buy	X
SNDX Syndax Pharmaceuticals Guggenheim
$34
9/4/25	Initiated	Buy	X
SPRY ARS Pharmaceuticals Roth Capital
$40
9/4/25	Resumed	Outperform	X
SQM Sociedad Quimica y Minera Itau BBA
$55
9/4/25	Upgrades	Neutral Outperform	X
STM STMicroelectronics BNP Paribas Exane
$31
9/4/25	Resumed	Neutral	X
TERN Terns Pharmaceuticals H.C. Wainwright
9/4/25	Initiated	Hold	X
TMDX TransMedics Group Stifel
$115
9/4/25	Downgrades	Outperform In-line	X
TXRH Texas Roadhouse Evercore ISI
$190
9/4/25	Resumed	Overweight	X
ULTA Ulta Beauty Piper Sandler
$590